MARATTO

article · Diabetology & Metabolic Syndrome

The relative risk of clinically relevant cholelithiasis among glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus, real-world study

20247 citationsOpen accessKafr el-Sheikh University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Diabetes Treatment and Management
  • Gastroesophageal reflux and treatments
  • Neuroendocrine Tumor Research Advances

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1186/s13098-024-01526-2

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.